Abstract:Abstract Background The aim of the study was to assess the perception of inflammatory bowel disease (IBD) among Chinese patients and physicians. Methods Data in this cross-sectional study was collected from 6/2020 to 8/2020, which covered 24 provinces/cities in China and based on two surveys that was designed for collecting information from patients with Crohn’s disease (CD)/ulcerative colitis (UC) and the physicians. Results Surveys were completed by 1058 patients (601 CD and 457 UC patients) and 351 physicians (181 treating CD and 170 treating UC). For the control of disease symptoms over the past 12 months, physicians believed that 65.19% and 57.65% of CD and UC patients, respectively, were managed without affecting their quality of life. Meanwhile, 56.07% and 49.46% of CD and UC patients, respectively, reported that disease control did not affect their quality of life. Physicians estimated that 87.85% of CD and 88.24% of UC patients were satisfied with treatment results. And 86.36% of CD and 79.43% of UC patients were satisfied with the current medications. Physicians prescribed biologics for 69.52% of IBD patients, and 48.3% of IBD patients actually used them. Repeated medication (30.95%), diarrhea (27.95%) and abdominal pain (25.29%) were most frequently ranked as most bothersome symptoms by CD patients. For physicians, abdominal pain (42.54%) was the most bothersome symptoms, followed by repeated medication (23.76%) and diarrhea (17.13%). Regarding UC symptoms, 51.18% of physicians believed that bloody stool was the most bothersome symptom for patients, and 41.58% of patients held this view. The sense of urgency was concerned as one bothersome symptom by 19.69% patients, while only 4.12% of physicians held the same views (Fig 1). Regarding the efficacy evaluation, in view of the CD physicians, 42.5% of CD patients were believed achieving completely or mostly controlled, while from the patients’ perception, only 32.6% of CD patients agreed. Similarly, the proportion of UC patients who was believed by physicians that achieving completely or mostly controlled (40.0%) was also higher than that of UC patients who believed by themselves (Fig 2). Conclusion Most of the IBD patients and physicians were satisfied with the treatment results and the current medications. The disease control expectation of the patients was slightly more than that of the physicians. Further studies are needed to explore factors that associated with the treatment expectation of the patients.

Expert consensus on the diagnosis and treatment model of inflammatory bowel disease multidisciplinary team in China

Multi-disciplinary Team for Diagnosis and Treatment of Inflammatory Bowel Disease

Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients

Perspectives Of Ibd China: Is Crohn'S And Colitis Foundation Model A Solution To Health Care Issues For The Country?

Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease

Challenging the Surge of IBD: The role of the China Crohn’s and Colitis Foundation in the healthcare landscape of IBD

Patients’ Views of Shared Decision Making in Inflammatory Bowel Disease: a Survey in China

IDDF2018-ABS-0181 Impact of internet and social media community on patients with inflammatory bowel diseases in china: a multicenter questionnaire survey

The Diagnosis Performance of the TCM Syndromes of Irritable Bowel Syndrome by Gastroenterologists Based on Modified Simple Criteria Compared to TCM Practitioners: A Prospective, Multicenter Preliminary Study

Anti-cytokine Therapy and Small Molecule Agents for the Treatment of Inflammatory Bowel Disease

Expert Consensus on Organizing the Multidisciplinary Team(mdt) Diagnosis and Treatment of Hepato-Pancreato-biliary Diseases in China

Experts guideline on pathological assessment of inflammatory bowel disease in China

Expert consensus on diagnosis and treatment of ulcerative colitis with integrated traditional Chinese and Western medicine: A nursing perspective

Management Consensus of Inflammatory Bowel Disease for the Asia–Pacific Region

Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing)

P467 Perception Gap Between Patients with Inflammatory Bowel Disease (IBD) and Physicians in China: A Cross-sectional Study

Disease Burden of Inflammatory Bowel Disease in China from 1990 to 2019 and Its Predictions

Expert guideline on imaging examination and report specification of inflammatory bowel disease in China

Investigation on status quo of tuberculosis screening in 1711 patients with inflammatory bowel diseases before infliximab therapy in China

Noninvasive, microbiome-based diagnosis of inflammatory bowel disease

Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel